FRAX and the effect of teriparatide on vertebral and non-vertebral fracture
Background: daily administration of 20µg or 40µg teriparatide has been shown to significantly decrease the risk of vertebral and non-vertebral fracture compared with placebo. The aim of the present study was to evaluate fracture risk assessed at baseline using the FRAX® tool and to determine the eff...
Main Authors: | Harvey, Nicholas C. (Author), Kanis, John A. (Author), Odén, Anders (Author), Burge, Russel T. (Author), Mitlak, Bruce H. (Author), Johansson, Helena (Author), McCloskey, Eugene (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2015-05-10.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX
by: Harvey, Nicholas C., et al.
Published: (2015) -
Effect of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX
by: Harvey, N.C, et al.
Published: (2015) -
Teriparatide and vertebral fracture healing in Ankylosing Spondylitis
by: Izolda Biro, et al.
Published: (2017-12-01) -
FRAX - A NEW TOOL FOR THE ASSESSMENT OF FRACTURE RISK: APPLICATION IN CLINICAL PRACTICE AND THRESHOLDS FOR INTERVENTION
by: J A Kanis, et al.
Published: (2012-08-01) -
Effect of Teriparatide on Subsequent Vertebral Fractures after Instrumented Fusion Surgery for Osteoporotic Vertebral Fractures with Neurological Deficits
by: Keishi Maruo, et al.
Published: (2019-04-01)